Bausch + Lomb Corp.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CA0717051076
USD
16.81
-0.15 (-0.88%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
{
  "main_header": {
    "sid": 1289684,
    "name": "Bausch + Lomb Corp.",
    "stock_name": "Bausch + Lomb Corp.",
    "full_name": "Bausch + Lomb Corp.",
    "name_url": "stocks-analysis/bausch-lomb-corp",
    "exchange": 207,
    "exchangecode": "NYS",
    "country_id": 2,
    "currency": "USD",
    "cmp": "16.81",
    "chg": -0.15,
    "chgp": "-0.88%",
    "dir": -1,
    "prev_price": "16.96",
    "mcapval": "5,492.00",
    "mcap": "Small Cap",
    "scripcode": "",
    "symbol": "",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 2325,
    "indexname": "S&P 500",
    "isin": "CA0717051076",
    "curr_date": "Dec 04",
    "curr_time": "",
    "bse_nse_vol": "136.13 k",
    "exc_status": "Active",
    "traded_date": "Dec 04, 2025",
    "traded_date_str": "2025 12 04",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-registerF-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/bausch-lomb-corp-1289684-207&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0
    }
  },
  "news": {
    "results": [
      {
        "title": "Bausch + Lomb Corp. Experiences Revision in Stock Evaluation Amid Mixed Technical Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bausch-lomb-corp-technical-trend-shifts-from-mildly-bearish-to-mildly-bullish-amid-stock-price-decline-3601422",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BauschLombCorp_technicaldot_3601422.png",
        "date": "2025-10-07 21:11:23",
        "description": "Bausch + Lomb Corp. has experienced a decline in stock value over the past year, underperforming the S&P 500. Technical indicators present a mixed outlook, with some suggesting short-term strength while others indicate a lack of definitive trends. The company faces ongoing challenges in a competitive market."
      },
      {
        "title": "Is Bausch + Lomb Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bausch-lomb-corp-technically-bullish-or-bearish-3599354",
        "imagepath": "",
        "date": "2025-10-07 12:24:57",
        "description": "As of 3 October 2025, the technical trend for Bausch + Lomb Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, supporting the positive shift, while the daily moving averages also indicate a bullish stance. However, the monthly MACD and Bollinger Bands remain bearish, suggesting mixed signals across different time frames. The stock has underperformed the S&P 500 across all multi-period returns, with a year-to-date decline of 17.55% compared to the S&P 500's gain of 14.18%. Overall, the current technical stance is mildly bullish, but caution is warranted due to the bearish monthly indicators...."
      },
      {
        "title": "Bausch + Lomb Forms Golden Cross, Signaling Potential Bullish Breakout Ahead",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/bausch-lomb-forms-golden-cross-signaling-potential-bullish-breakout-ahead-3595308",
        "imagepath": "https://i.marketsmojo.com/newsimg/2025/10/BauschLombCorp_goldencross_3595308.png",
        "date": "2025-10-06 15:34:47",
        "description": "Bausch + Lomb Corp. has recently experienced a Golden Cross, indicating a potential shift in momentum. While daily indicators show a bullish trend, mixed signals arise from the monthly MACD. The company has faced challenges over the past year, but recent trading suggests resilience amid fluctuating performance metrics."
      },
      {
        "title": "Is Bausch + Lomb Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bausch-lomb-corp-technically-bullish-or-bearish-3592155",
        "imagepath": "",
        "date": "2025-10-05 12:00:37",
        "description": "As of 3 October 2025, the technical trend for Bausch + Lomb Corp. has changed from mildly bearish to mildly bullish. The weekly MACD is bullish, and the daily moving averages are also bullish, supporting the positive shift. However, the monthly MACD remains bearish, indicating some caution. The Bollinger Bands show a bullish signal on the weekly timeframe but are mildly bearish on the monthly. The KST is bullish on the weekly, while the OBV is mildly bearish. Overall, the current stance is mildly bullish, though mixed signals from the longer-term indicators suggest caution.\n\nIn terms of performance, Bausch + Lomb has underperformed the S&P 500 year-to-date with a return of -15.84% compared to the S&P's 14.18%, and it has also lagged over the past year with a return of -19.49% versus 17.82% for the benchmark...."
      },
      {
        "title": "Is Bausch + Lomb Corp. technically bullish or bearish?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bausch-lomb-corp-technically-bullish-or-bearish-3548277",
        "imagepath": "",
        "date": "2025-09-20 20:13:56",
        "description": "As of 8 September 2025, the technical trend for Bausch + Lomb Corp. has changed from mildly bearish to sideways. The current stance is neutral, with mixed signals across various indicators. The weekly MACD is bullish, while the monthly MACD is bearish. The Bollinger Bands indicate a bullish trend on the weekly chart but are mildly bearish on the monthly. Moving averages are showing a mildly bearish signal on the daily timeframe. Dow Theory suggests a mildly bullish outlook on both weekly and monthly timeframes. \n\nIn terms of performance, Bausch + Lomb has underperformed the S&P 500 across multiple periods, with a year-to-date return of -14.84% compared to the S&P's 12.22%, and a one-year return of -23.1% versus the S&P's 17.14%...."
      },
      {
        "title": "Is Bausch + Lomb Corp. overvalued or undervalued?",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/is-bausch-lomb-corp-overvalued-or-undervalued-3544365",
        "imagepath": "",
        "date": "2025-09-20 18:44:20",
        "description": "As of 3 May 2023, the valuation grade for Bausch + Lomb Corp. has moved from expensive to risky, indicating a shift in perception regarding its financial health and market position. The company appears to be overvalued, given its Price to Book Value of 0.65 and an EV to EBITDA ratio of 14.88, which suggests that investors are paying a premium despite the company's current losses. Additionally, the ROCE stands at a mere 1.42%, further highlighting the challenges the company faces in generating returns.\n\nIn comparison to its peers, Bausch + Lomb's valuation metrics are concerning; for instance, Penumbra, Inc. has a significantly higher P/E ratio of 75.41, while QIAGEN NV, which is considered fairly valued, has a more reasonable EV to EBITDA of 15.05. The company's recent stock performance has also lagged behind the S&P 500, with a year-to-date return of -14.84% compared to the index's gain of 12.22%. Overall,..."
      }
    ],
    "total": 10,
    "sid": "1289684",
    "stock_news_url": "https://www.marketsmojo.com/news/bausch-lomb-corp-1289684"
  },
  "announcements": "",
  "corporate_actions": {
    "msg": "No corporate action Found"
  }
}
stock newsNews and Views
stock-recommendationAnnouncement
Icon
No announcement available
stock-recommendationCorporate Actions
Corporate Actions
info
Icon
No corporate action available